Though not on the focus list, joint replacement manufacturer Biomet (nasdaq: BMET - news - people ) should outperform its peers this year, Moroney says.
Also in health care, Moroney cites consistent growth and solid finances as factors that should boost Biomet (nasdaq: BMET - news - people ) and Lincare Holdings (nasdaq: LNCR - news - people ).